Clinical Trials Browser

Phase 3 × NIH × Sunitinib × Clear all

NCT00326898 2022-02-08

ASSURE

Phase 3 Completed

1,943 enrolled 12 charts

Carcinoma, Renal Cell

NCT00693992 2019-06-11

Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

Phase 3 Completed

210 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung